Total Clarity Wealth Management, Inc. Biogen Inc. Transaction History

Total Clarity Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$187.54 - $223.02 $30,006 - $35,683	160 New	160 $33,000
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $26,158 - $32,958	-135 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $38,203 - $49,821	135 New	135 $38,000
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $34,965 - $55,985	-135 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$242.95 - $284.63 $32,798 - $38,425	135 New	135 $38,000
Q1 2020 Apr 24, 2020	SELL	$268.85 - $341.04 $36,294 - $46,040	-135 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$220.06 - $304.07 $29,708 - $41,049	135 New	135 $40,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.